Decoy Therapeutics (DCOY) Dividends Paid - Common (2018 - 2019)
Decoy Therapeutics (DCOY) posted quarterly Dividends Paid - Common of $33836.0 for Q3 2019, up 157.39% quarter-over-quarter from -$58959.0 in Q4 2018.
Decoy Therapeutics (DCOY) Dividends Paid - Common (2018 - 2019) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Dividends Paid - Common for 2 consecutive years, with $33836.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Dividends Paid - Common changed N/A year-over-year to $33836.0; the TTM figure through Dec 2020 stood at $33836.0 (changed N/A YoY), while the FY2019 annual figure was $133594.0, changed N/A from the prior year.
- Dividends Paid - Common grew to $33836.0 in Q3 2019 per DCOY's latest filing, from -$58959.0 in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $33836.0 in Q3 2019 and bottomed at -$58959.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 34.60 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 33,836.00 |
| Sep 30, 2019 | 33,836.00 |
| Dec 31, 2018 | -58,959.00 |
| Dec 31, 2018 | -58,959.00 |